Clinical trial
A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma
NCT04250064 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma
- Lead sponsor
- Tata Memorial Centre
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 4, 2020
- Completion date
- December 31, 2029
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dipg